JAK2 — Drug Target

All drugs that target JAK2 — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

JAK2 inhibitor · JAK inhibitor

Phase 2 pipeline (2)

• AT7519M · Astex Pharmaceuticals, Inc. · JAK2 inhibitor · Oncology
  AT7519M is a potent inhibitor of the JAK2 protein.
• Oral Fedratinib · Celgene · JAK inhibitor · Oncology
  JAK2 inhibitor

Phase 1 pipeline (1)

• A: pacritinib · CTI BioPharma · JAK inhibitor · Oncology
  JAK2 inhibitor